✉news ScienceBiology first seen 22 h ago, last 17 h ago, peak #28
BostonGene to Present AI Approach in Cancer Drug Development
Original: BostonGene Chief Medical Officer to Discuss Biologically Grounded AI and Multimodal Data in Oncology Drug Development at the 2nd Annual Global Cancer Research & Innovation Symposium
BostonGene's Chief Medical Officer is scheduled to speak at the 2nd Annual Global Cancer Research & Innovation Symposium, where the focus will be on biologically grounded artificial intelligence and the use of multimodal data in oncology drug development. The company argues that combining AI with biological context can improve how cancer therapies are discovered and developed.
Why now: Interest in AI-driven cancer research and BostonGene's role in oncology drug development is drawing attention to the company's conference appearance.
BostonGeneGlobal Cancer Research & Innovation Symposium
Rank over time, top of the chart is #1. 4 snapshots from 22 h ago to 17 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/657709